# Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-17

> **NCT03462576** · — · TERMINATED · sponsor: **Meridian Bioscience, Inc.** · enrollment: 199 (actual)

## Conditions studied

- Decompensated Cirrhosis

## Interventions

- **COMBINATION_PRODUCT:** Methacetin Breath Test
- **DRUG:** Emricasan
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03462576
- **Lead sponsor:** Meridian Bioscience, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-28
- **Primary completion:** 2019-07-15
- **Final completion:** 2019-07-15
- **Target enrollment:** 199 (ACTUAL)
- **Why stopped:** Sponsor of Trial decision
- **Last updated:** 2022-12-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03462576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03462576, "Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-17". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03462576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*